Antimicrobial resistance profiles of diarrhoeagenic Escherichia coli isolated from travellers returning to the UK, 2015-2017.

Introduction. Diarrhoeagenic Escherichia coli (DEC) are difficult to distinguish from non-pathogenic commensal E. coli using traditional culture methods. The implementation of PCR targeting specific virulence genes characteristic of the five DEC pathotypes, has improved the detection of DEC in faecal specimens from patients with symptoms of gastrointestinal disease.Aim. Antimicrobial resistance (AMR) profiles of 660 strains of DEC isolated between 2015 and 2017 from UK travellers reporting symptoms of gastrointestinal disease were reviewed to look for evidence of emerging AMR associated with travellers' diarrhoea.Methodology. All isolates of DEC were sequenced, and sequence type, serotype, pathotype markers and AMR profiles were derived from the genome data.Results. A travel history was provided for 54.1 % (357/660) of cases, of which 77.0 % (275/357) reported travel outside the UK within 7 days of onset of symptoms, and 23.0 % (82/357) reported no travel in that time frame. Of the 660 strains of DEC in this study, 265 (40.2 %) samples were identified as EAEC, 48 (7.3 %) as EIEC, 61 (9.2 %) were ETEC and 286 (43.3 %) were EPEC. EPEC caused the highest percentage of infections in children (40.6 %) whilst the highest proportion of cases reporting recent travel were infected with ETEC (86.1 %). There were 390/660 (59.0 %) isolates resistant to at least one antimicrobial on the panel tested (EIEC, 81.3 %; ETEC, n=65.6 %; EAEC, n=73.2 %; EPEC, 40.9 %) and 265/660 (40.2 %) were multidrug-resistant (EIEC, 33.3 %; ETEC, 32.8 %; EAEC, 56.2 %; EPEC, 28.0 %). Genes conferring resistance to the beta-lactams and fluroquinolones were highest in the EAEC pathotype, 56.6 and 60.7%, respectively.Conclusions. Increasing MDR, along with resistance to the fluroquinolones and the third-generation cephalosporins, in DEC causing travellers' diarrhoea provides further evidence for the need to restrict the use of antimicrobial agents and continuous monitoring.

[1]  Lisa C. Crossman,et al.  Identification and characterisation of enteroaggregative Escherichia coli subtypes associated with human disease , 2020, Scientific Reports.

[2]  K. Hopkins,et al.  Antimicrobial resistance in Shiga toxin-producing Escherichia coli other than serotype O157 : H7 in England, 2014-2016. , 2020, Journal of medical microbiology.

[3]  J. Fleckenstein,et al.  Enterotoxigenic Escherichia coli Infections , 2019, Current Infectious Disease Reports.

[4]  T. Dallman,et al.  Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species , 2018, Nature Communications.

[5]  Neil Woodford,et al.  Prediction of Phenotypic Antimicrobial Resistance Profiles From Whole Genome Sequences of Non-typhoidal Salmonella enterica , 2018, Front. Microbiol..

[6]  N. Woodford,et al.  Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of enteroaggregative Escherichia coli isolated from cases of diarrhoeal disease in England, 2015–16 , 2017, The Journal of antimicrobial chemotherapy.

[7]  T. Dallman,et al.  Identification of Escherichia coli and Shigella Species from Whole-Genome Sequences , 2016, Journal of Clinical Microbiology.

[8]  I. Stolte,et al.  Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  P. Ashton,et al.  Whole Genome Sequencing for Public Health Surveillance of Shiga Toxin-Producing Escherichia coli Other than Serogroup O157 , 2016, Front. Microbiol..

[10]  A. Manges,et al.  Reservoirs of Extraintestinal Pathogenic Escherichia coli , 2015, Microbiology spectrum.

[11]  W. Schaik.  The human gut resistome , 2015 .

[12]  Richard J Ellis,et al.  Whole-genome sequencing for national surveillance of Shiga toxin-producing Escherichia coli O157. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Ollgren,et al.  Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. Jenkins,et al.  Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013. , 2014, Journal of medical microbiology.

[15]  P. Savelkoul,et al.  High Rates of Antimicrobial Drug Resistance Gene Acquisition after International Travel, the Netherlands , 2014, Emerging Infectious Diseases.

[16]  C. Jenkins,et al.  An update on the microbiology and epidemiology of enteropathogenic Escherichia coli in England 2010-2012. , 2013, Journal of medical microbiology.

[17]  B. Finlay,et al.  Recent Advances in Understanding Enteric Pathogenic Escherichia coli , 2013, Clinical Microbiology Reviews.

[18]  C. Jenkins,et al.  Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli. , 2012, Journal of medical microbiology.

[19]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[20]  J. Vila,et al.  CTX-M-15–producing Enteroaggregative Escherichia coli as Cause of Travelers’ Diarrhea , 2011, Emerging infectious diseases.

[21]  G. Peirano,et al.  Colonization of returning travelers with CTX-M-producing Escherichia coli. , 2011, Journal of travel medicine.

[22]  I. Odenholt,et al.  Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea , 2010, Scandinavian journal of infectious diseases.

[23]  P. Hawkey,et al.  The changing epidemiology of resistance. , 2009, The Journal of antimicrobial chemotherapy.

[24]  L. D. Del Valle,et al.  High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru. , 2009, The American journal of tropical medicine and hygiene.

[25]  J. Ruiz,et al.  Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea. , 2009, The Journal of antimicrobial chemotherapy.

[26]  M. Ballal,et al.  Multidrug resistant enteroaggregative Escherichia coli diarrhoea in rural southern Indian population , 2009, Scandinavian journal of infectious diseases.

[27]  D. Church,et al.  Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. , 2008, The Journal of infection.

[28]  D. Tompkins,et al.  Serotypes, intimin subtypes, and antimicrobial resistance patterns of atypical enteropathogenic Escherichia coli isolated in England from 1993 to 1996 , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[29]  G. Dougan,et al.  Subtyping intimin genes from enteropathogenic Escherichia coli associated with outbreaks and sporadic cases in the United Kingdom and Eire. , 2003, Molecular and cellular probes.

[30]  E. Suffredini,et al.  Pathogenicity assessment of Shiga toxin‐producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC , 2020 .

[31]  Neil Woodford,et al.  Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England, 2015 , 2017, The Journal of antimicrobial chemotherapy.

[32]  Mathias W Pletz,et al.  Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. , 2015, International journal of medical microbiology : IJMM.

[33]  Y. Dong,et al.  Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  B. Finlay,et al.  Molecular mechanisms of Escherichia coli pathogenicity , 2012, Nature Reviews Microbiology.

[35]  G. Rossolini,et al.  The spread of CTX-M-type extended-spectrum β-lactamases , 2008 .

[36]  H. Boga,et al.  High incidence of enteroaggregative Escherichia coli among food handlers in three areas of Kenya: a possible transmission route of travelers' diarrhea. , 2008, Journal of travel medicine.

[37]  D. Tompkins,et al.  Characterisation of strains of enteroaggregative Escherichia coli isolated during the infectious intestinal disease study in England , 2004, European Journal of Epidemiology.